Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
CYTK on Nasdaq
Robert I. Blum - trading volume in the past year for Cytokinetics Inc
Holdings reported by Robert I. Blum for Cytokinetics Inc
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
423K |
$15.5M |
$36.77 |
Apr 10, 2025 |
Direct |
|
|
| Non-Qualified Stock Option (Right to Buy) |
113K |
$2.9M |
$41.69 |
Jul 10, 2024 |
Direct |
Common Stock |
|
| Incentive Stock Option (Right to Buy) |
2.25K |
$84.8K |
$37.63 |
Mar 14, 2025 |
Direct |
Common Stock |
|
| Common Stock |
2.08K |
$76.6K |
$36.77 |
Apr 10, 2025 |
by Trust 1 |
|
|
| Common Stock |
2.08K |
$76.6K |
$36.77 |
Apr 10, 2025 |
by Trust 2 |
|
|
| Non-Qualified Stock Option (Right to Buy) |
177K |
|
|
Mar 14, 2025 |
Direct |
Common Stock |
|
Transactions reported by Robert I. Blum for Cytokinetics Inc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.